Furthermore, Kaplan-Meier survival analysis revealed that the higher expression of VAMP5, TIGIT, LCK, CHORDC1, CD27, and CACYBP was correlated with better outcomes in bladder cancer patients treated with immunotherapy (Fig. 2B). The gene discussed is LCK; the disease is urinary bladder carcinoma.